IMARC Group, a leading market research company, has recently releases report titled, “Metabolomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global metabolomics market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big is the metabolomics market?
Market Size in 2022
US$ 2.4 Billion
Market Forecast in 2028
US$ 4.7 Billion
Growth rate (2023 to 2028)
CAGR of 11.55%
Base Year of the Analysis
What is metabolomics?
Metabolomics is the study and analysis of small molecules present in cells, biofluids, tissues, and organisms. It includes various steps, such as the acquisition, separation, detection of analytes, and data mining and extraction, and analysis. It involves various analytic techniques, such as nuclear magnetic resonance (NMR) spectroscopy and high-resolution mass spectrometry (HRMS). It serves as an effective tool in the diagnosis of a disease and facilitates the prediction of treatment response and survival. As it is also employed to detect the recurrence of a disease after therapy, metabolomics is gaining traction in biomarker and drug discovery, toxicology, nutrigenomics, and personalized medicines across the globe.
Request Free Sample Report (Exclusive Offer on this report):https://www.imarcgroup.com/metabolomics-market/requestsample
What are the growth prospects and trends in the metabolomics industry?
At present, the growing global geriatric population and increasing prevalence of cancer and various cardiovascular and neurological disorders represent one of the key factors positively influencing the market. In addition, rising cases of inborn errors of metabolism (IEM), such as fructose intolerance, maple syrup urine disease (MSUD), fatty acid oxidation defects, mitochondrial disorders, and phenylketonuria (PKU) are catalyzing the demand for untargeted metabolomics for IEM screening worldwide. In line with this, increasing investments in research and development (R&D) activities and rising integration of machine learning (ML) algorithms with metabolomics to identify weight gain biomarkers is fueling the growth of the market.
What is included in market segmentation?
The report has segmented the market into the following categories:
Insights on Market Segmentation:Market Breakup by Product:
Metabolomics Bioinformatics Tools and Services
Market Breakup by Indication:
Inborn Errors of Metabolism
Market Breakup by Application:
Biomarker and Drug Discovery
Market Segmentation by Region:
Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
Agilent Technologies, Inc. (A)
Biocrates Life Sciences AG
Bio-Rad Laboratories, Inc. (BIO)
Bruker Corporation (BRKR)
Danaher Corporation (DHR)
HUMAN METABOLOME TECHNOLOGIES I (6090.T)
SHIMADZU CORP (SHMZF)
Thermo Fisher Scientific Inc.
Waters Corporation, etc.
Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=2024&flag=CIf you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal